Table 3.
The Distribution of Various Isolates Obtained from Cases of CRBSI
| Pathogen | MDRB N (%) | N (%) |
|---|---|---|
| Gram-positive bacteria | 12(42.86%) | 28(31.11%) |
| Enterococcus faecalis | 0(0.00%) a | 2(2.22%) |
| Enterococcus faecium | 2(22.22%) a | 9(10.00%) |
| Staphylococcus aureus | 2(100.00%) b | 2(2.22%) |
| Staphylococcus epidermidis | 6(85.71%) b | 7(7.78%) |
| Staphylococcus haemolyticus | 2(100.00%) b | 2(2.22%) |
| Streptococcus | 0(0.00%) a | 6(6.67%) |
| Gram-negative bacteria | 20(50.00%) | 40(44.44%) |
| Escherichia coli | 0(0.00%) c | 7(7.78%) |
| Klebsiella pneumoniae | 12(80%) c | 15(16.67%) |
| Acinetobacter baumannii | 4(66.67%) c | 6(6.67%) |
| Pseudomonas aeruginosa | 1(33.33%) c | 3(3.33%) |
| Pseudomonas maltophilia | 0(0.00%) d | 3(3.33%) |
| Other Gram-negative bacteria | 3(50.00%) c | 6(6.67%) |
| Fungus | 4(18.18%) | 22(24.44%) |
| Candida albicans | 0(0.00%) e | 8(8.89%) |
| Candida glabrata | 0(0.00%) e | 2(2.22%) |
| Candida parapsilosis | 0(0.00%) e | 4(4.44%) |
| Candida tropicalis | 4(50.00%) e | 8(8.89%) |
| Overall | 36(40.00%) | 90(100.00%) |
Notes: aVancomycin resistant, bOxacillin resistant, cCarbapenems resistant (including meropenem and imipenem), dLevofloxacin resistant, eFluconazole resistant.
Abbreviation: MDRB, Multidrug-resistant bacteria.